Navigation Links
Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding
Date:2/11/2008

KENSINGTON, Md., Feb. 11 /PRNewswire-USNewswire/ -- "Psoriasis Cure Now," a nonprofit patient advocacy group, today applauded Congress and the National Institutes of Health (NIH) for delivering a record $10 million in psoriasis research funding during fiscal year 2007. Psoriasis research has traditionally been underfunded at NIH. Since 1995, NIH funding on other diseases has risen 159% (before inflation), but psoriasis and psoriatic arthritis research had been stuck between $5 and $6 million every year from FY 1995 until FY 2006, when it reached $8 million, and now $10 million in FY 2007.

"Psoriasis Cure Now was founded in 2005 because it was disturbing to see psoriasis research funding not even keep pace with inflation as research on other diseases more than doubled," said Michael Paranzino, president of Psoriasis Cure Now. "We are thrilled to see Congress and NIH working to reverse this funding shortfall with the second significant funding increase in a row."

Even after two years of strong growth, psoriasis research at NIH remains $40 million short of what would have been invested in psoriasis research had its funding merely kept pace with NIH's growth since 1995. Psoriasis Cure Now has urged policymakers to increase annual psoriasis and psoriatic arthritis research to $20 million by 2010, reflecting the disease's severe impact on millions of Americans and the years that were lost as psoriasis funding languished.

"Many people helped get funding for psoriasis research moving in the right direction," Paranzino added, "from the citizens who wrote letters to and visited with their lawmakers, to leaders like Reps. Rosa DeLauro, Ralph Regula and Jim Gerlach, Chairmen Tom Harkin and David Obey, and Senator Arlen Specter. The NIH and NIAMS leadership also deserve our thanks for supporting valuable research that will lead to treatment breakthroughs in the years ahead. With new research linking psoriasis to increased risk of heart attack and even premature death, continued increases in psoriasis research could not be more timely."

For more information, visit the Psoriasis Cure Now homepage at http://www.psoriasis-cure-now.org.


'/>"/>
SOURCE Psoriasis Cure Now
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
2. Americas Next Top Model Steps up for Psoriasis Awareness
3. Chicagoland Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day
4. Psoriasis Cure Now Rolls Out First National Short Sleeve Day Saturday
5. DC Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day
6. Salt Lake City Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day
7. San Francisco Psoriasis Event Tonight Will Celebrate First National Short Sleeve Day
8. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
9. National Psoriasis Foundation Marks World Psoriasis Day With Call to Support Psoriasis Legislation
10. New study shows smoking increases risk of psoriasis
11. $6.37 million from National Institutes of Health to find new ways to treat psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces the ... instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ... hour rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: